Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 6, 2005 - Issue 2
Submit an article Journal homepage
157
Views
19
CrossRef citations to date
0
Altmetric
Drug Evaluation

Dutasteride: a novel dual inhibitor of 5α-reductase for benign prostatic hyperplasia

Bob Djavan University of Vienna, Department of Urology, AKH Ebene 8D, Wahringer Gurtel 18-20, 1090 Wien, Austria. [email protected]
,
Shirin Milani University of Vienna, Vienna, Austria
&
Yan Kit Fong University of Vienna, Vienna, Austria
Pages 311-317 | Published online: 22 Apr 2005

Citations (19)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Guruprasad Varma Konduru & Hampapathalu Adimurthy Nagarajaram. (2023) Human TMPRSS2 non-catalytic ectodomain and SARS-CoV-2 S2' subunit interaction mediated SARS-CoV-2 endocytosis: a model proposal with virtual screening for potential drug molecules to inhibit this interaction. Journal of Biomolecular Structure and Dynamics 41:13, pages 6422-6433.
Read now
Patience N. Ogbu, Evelyn O. Ugota, Rita U. Onwuka, Ikechukwu M. Ogbu & Chinyere Aloke. (2020) Effect of acetogenin fraction of Annona muricata leaves on antioxidant status and some indices of benign prostatic hyperplasia in rats. Redox Report 25:1, pages 80-86.
Read now
Rajnish Kumar, Priyanka Malla & Manoj Kumar. (2013) Advances in the design and discovery of drugs for the treatment of prostatic hyperplasia. Expert Opinion on Drug Discovery 8:8, pages 1013-1027.
Read now
Bob Djavan, Markus Johannes Handl & Saeid Dianat. (2010) Combined medical treatment using dutasteride and tamsulosin for lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Expert Opinion on Pharmacotherapy 11:15, pages 2535-2547.
Read now

Articles from other publishers (15)

Nikolaos Nikolaou, Leanne Hodson & Jeremy W. Tomlinson. (2021) The role of 5-reduction in physiology and metabolic disease: evidence from cellular, pre-clinical and human studies. The Journal of Steroid Biochemistry and Molecular Biology 207, pages 105808.
Crossref
Ting Yin, Zhanbing Qiao, You Li, Dezhi Li, Min Jiang, Chao An, Fen Wang, Minghuan Zuo, Kaiwen Hu & Quanwang Li. (2017) Comparisons of the Efficacy and Safety of Finasteride and Dutasteride for Benign Prostatic Hyperplasia: A Network Meta-Analysis. American Journal of Therapeutics 24:5, pages e517-e523.
Crossref
Ruben Vardanyan & Victor Hruby. 2016. Synthesis of Best-Seller Drugs. Synthesis of Best-Seller Drugs 459 493 .
Tae Beom Kim, Jin Kyu Oh, Khae Hawn Kim, Han Jung, Sang Jin Yoon, Min Sung Lee & Soo Woong Kim. (2012) Dutasteride, who is it more effective for? Second to fourth digit ratio and the relationship with prostate volume reduction by dutasteride treatment. BJU International 110:11c.
Crossref
Juergen Sandow. 2003. Ullmann's Encyclopedia of Industrial Chemistry. Ullmann's Encyclopedia of Industrial Chemistry.
René Maltais & Donald Poirier. (2011) Steroid sulfatase inhibitors: A review covering the promising 2000–2010 decade. Steroids 76:10-11, pages 929-948.
Crossref
Jürgen Sandow. 2011. Drug Discovery and Evaluation: Methods in Clinical Pharmacology. Drug Discovery and Evaluation: Methods in Clinical Pharmacology 489 521 .
J.A. Arratia-Maqueo, R. Garza-Cortés, L.S. Gómez-Guerra & J.R. Cortés-González. (2010) Efecto en el sangrado perioperatorio durante la resección transuretral de la próstata tras un mes de tratamiento con dutasteride. Actas Urológicas Españolas 34:10, pages 866-869.
Crossref
J.A. Arratia-Maqueo, R. Garza-Cortés, L.S. Gómez-Guerra & J.R. Cortés-González. (2010) Effect of one month treatment with dutasteride on transurethral resection of the prostate. Actas Urológicas Españolas (English Edition) 34:10, pages 866-869.
Crossref
Suresh Thareja, Saurabh Aggarwal, T.R. Bhardwaj & Manoj Kumar. (2009) Self organizing molecular field analysis on a series of human 5α-reductase inhibitors: Unsaturated 3-carboxysteroid. European Journal of Medicinal Chemistry 44:12, pages 4920-4925.
Crossref
Gerald L. Andriole. (2009) Overview of Pivotal Studies for Prostate Cancer Risk Reduction, Past and Present. Urology 73:5, pages S36-S43.
Crossref
Donald Poirier. (2008) New cancer drugs targeting the biosynthesis of estrogens and androgens. Drug Development Research 69:6, pages 304-318.
Crossref
Diego Barral Tafalla, Silvana Maluf Saladín, Germán Kreis Esmendi & Magí Farré Albaladejo. (2007) Ginecomastia y dutasterida. Medicina Clínica 129:15, pages 597.
Crossref
Jens Hoffmann & Anette Sommer. 2007. Cancer. Cancer 19 82 .
Michael G. Wyllie. (2005) The underlying pathophysiology and causes of erectile dysfunction. Clinical Cornerstone 7:1, pages 19-26.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.